MRI features suggestive of gadolinium retention do not correlate with Expanded Disability Status Scale worsening in Multiple Sclerosis

Disability Outcome Measures in Phase III Clinical Trials in Multiple Sclerosis

(2018) Bernard M. J. Uitdehaag   CNS DRUGS

One-year Retention of Gadolinium in the Brain: Comparison of Gadodiamide and Gadoterate Meglumine in a Rodent Model

(2018) Philippe Robert et al.   RADIOLOGY

Gadolinium Retention: A Research Roadmap from the 2018 NIH/ACR/RSNA Workshop on Gadolinium Chelates

(2018) Robert J. McDonald et al.   RADIOLOGY

Gadolinium deposition in the brain: summary of evidence and recommendations

(2017) Vikas Gulani et al.   LANCET NEUROLOGY

Gadolinium retention in the body: what we know and what we can do

(2017) Enrico Tedeschi et al.   Radiologia Medica

Clearance of Gadolinium from the Brain with No Pathologic Effect after Repeated Administration of Gadodiamide in Healthy Rats: An Analytical and Histologic Study

(2017) Adrian P. L. Smith et al.   RADIOLOGY

RESUME: Turning an SWI acquisition into a fast qMRI protocol

(2017) Serena Monti et al.   PLoS One

Gadolinium in Humans: A Family of Disorders

(2016) Richard C. Semelka et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms

(2016) Moshe Rogosnitzky et al.   BIOMETALS

Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast

(2016) Donna R. Roberts et al.   BRAIN & DEVELOPMENT

In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents

(2016) Enrico Tedeschi et al.   EUROPEAN RADIOLOGY

Presumed Gadolinium Toxicity in Subjects With Normal Renal Function

(2016) Richard C. Semelka et al.   INVESTIGATIVE RADIOLOGY

Macrocyclic and Other Non–Group 1 Gadolinium Contrast Agents Deposit Low Levels of Gadolinium in Brain and Bone Tissue

(2016) Nozomu Murata et al.   INVESTIGATIVE RADIOLOGY

Self-reported gadolinium toxicity: A survey of patients with chronic symptoms

(2016) Lauren M.B. Burke et al.   MAGNETIC RESONANCE IMAGING

Gadolinium deposition disease: Initial description of a disease that has been around for a while

(2016) Richard C. Semelka et al.   MAGNETIC RESONANCE IMAGING

Parallel Comparative Studies on Mouse Toxicity of Oxide Nanoparticle- and Gadolinium-Based T1 MRI Contrast Agents

(2015) Rui Chen et al.   ACS Nano

Defining reliable disability outcomes in multiple sclerosis

(2015) Tomas Kalincik et al.   BRAIN

Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study

(2015) Jeffrey A Cohen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents

(2015) Joana Ramalho et al.   RADIOLOGY

Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy

(2015) Tomonori Kanda et al.   RADIOLOGY

Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging

(2015) Robert J. McDonald et al.   RADIOLOGY

Improving Signal-to-Noise Ratio in Susceptibility Weighted Imaging: A Novel Multicomponent Non-Local Approach

(2015) Pasquale Borrelli et al.   PLoS One

A Novel Multiparametric Approach to 3D Quantitative MRI of the Brain

(2015) Giuseppe Palma et al.   PLoS One

Gadolinium Contrast Agents for CNS Imaging: Current Concepts and Clinical Evidence

(2014) E. Kanal et al.   AMERICAN JOURNAL OF NEURORADIOLOGY

Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis

(2014) Sandra Meyer-Moock et al.   BMC Neurology

Gadolinium induced recurrent acute pancreatitis

(2013) H. Blasco-Perrin et al.   PANCREATOLOGY

High Signal Intensity in the Dentate Nucleus and Globus Pallidus on Unenhanced T1-weighted MR Images: Relationship with Increasing Cumulative Dose of a Gadolinium-based Contrast Material

(2013) Tomonori Kanda et al.   RADIOLOGY

Immediate Hypersensitivity Reaction to Gadolinium-based MR Contrast Media

(2012) Jae-Woo Jung et al.   RADIOLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Evaluating and reducing the impact of white matter lesions on brain volume measurements

(2011) Marco Battaglini et al.   HUMAN BRAIN MAPPING

Primer on gadolinium chemistry

(2009) A. Dean Sherry et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Biodistribution of gadolinium-based contrast agents, including gadolinium deposition

(2009) Silvio Aime et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Persistence of Gadolinium Contrast Enhancement in CSF: A Possible Harbinger of Gadolinium Neurotoxicity?: Fig 1.

(2008) F.K. Hui et al.   AMERICAN JOURNAL OF NEURORADIOLOGY